Evidence map›Paper›PMID 27217486›Full record

ArticleDiabetes2016

Overexpressing IRS1 in Endothelial Cells Enhances Angioblast Differentiation and Wound Healing in Diabetes and Insulin Resistance.

Sayaka Katagiri, Kyoungmin Park, Yasutaka Maeda, Tata Nageswara Rao, Mogher Khamaisi, Qian Li, Hisashi Yokomizo, Akira Mima, Luca Lancerotto, Amy Wagers and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Effect of Insulin-Regulated FOXC2 Expression in Adipocyte Differentiation and Insulin Resistance.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Article
  15. Review
  16. Review
  17. Article
  18. Etiology of Metabolic Syndrome and Dietary Intervention.International journal of molecular sciences · 2018
    Review
  19. Review
  20. Endothelial cell calpain as a critical modulator of angiogenesis.Biochimica et biophysica acta. Molecular basis of disease · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Sayaka KatagiriSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Kyoungmin ParkSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Yasutaka MaedaSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Tata Nageswara RaoDepartment of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Joslin Diabetes Center, Havard Medical School, Boston, MA.
Mogher KhamaisiSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Qian LiSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Hisashi YokomizoSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Akira MimaSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Luca LancerottoDivision of Plastic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Amy WagersDepartment of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Joslin Diabetes Center, Havard Medical School, Boston, MA.
Dennis P OrgillDivision of Plastic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
George L KingSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA george.king@joslin.harvard.edu.
Harvard University · USJoslin Diabetes Center · USBrigham and Women's Hospital · USHarvard Stem Cell Institute · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
SELECTIVE INSULIN RESISTANCE--DIABETIC VASCULAR DISEASER01DK053105 · NIDDK · JOSLIN DIABETES CENTER · PI KING, GEORGE L · 1997 to 2017
$5.0M
NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK053105
6 · The paper itself

Abstract

The effect of enhancing insulin's actions in endothelial cells (ECs) to improve angiogenesis and wound healing was studied in obesity and diabetes. Insulin receptor substrate 1 (IRS1) was overexpressed in ECs using the VE-cadherin promoter to create ECIRS1 TG mice, which elevated pAkt activation and expressions of vascular endothelial growth factor (VEGF), Flk1, and VE-cadherin in ECs and granulation tissues (GTs) of full-thickness wounds. Open wound and epithelialization rates and angiogenesis significantly improved in normal mice and high fat (HF) diet-induced diabetic mice with hyperinsulinemia in ECIRS1 TG versus wild type (WT), but not in insulin-deficient diabetic mice. Increased angioblasts and EC numbers in GT of ECIRS1 mice were due to proliferation in situ rather than uptake. GT in HF-fed diabetic mice exhibited parallel decreases in insulin and VEGF-induced pAkt and EC numbers by >50% without changes in angioblasts versus WT mice, which were improved in ECIRS1 TG mice on normal chow or HF diet. Thus, HF-induced diabetes impaired angiogenesis by inhibiting insulin signaling in GT to decrease the differentiation of angioblasts to EC, which was normalized by enhancing insulin's action targeted to EC, a potential target to improve wound healing in diabetes and obesity.

Indexed as

AnimalsDiabetes Mellitus, ExperimentalDiet, High-FatEndothelial CellsFlow CytometryFluorescent Antibody TechniqueImmunoblottingInsulin Receptor Substrate ProteinsInsulin ResistanceMiceMice, Inbred C57BLMice, TransgenicReal-Time Polymerase Chain ReactionVascular Endothelial Growth Factor AWound HealingInsulin Receptor Substrate ProteinsVascular Endothelial Growth Factor A

Identifiers

PMID27217486
PMCPMC5001189
OpenAlexW2394612345

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.